[The development of therapeutics targeting oxidative stress in prostate cancer]

Masaki Shiota, Akira Yokomizo, Seiji Naito

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Oxidative stress is caused by increased reactive-oxygen species (ROS) due to augmented ROS production and impaired anti-oxidative capacity. Recently, oxidative stress has been revealed to promote castration resistance via androgen receptor(AR)-dependent pathway such as AR overexpression, AR cofactor, and AR post-translational modification as well as AR-independent pathway, leading to the emergence of castration-resistant prostate cancer (CRPC). Therefore, antioxidants therapy using natural and chemical ROS scavengers and inhibitors of ROS production seems to be a promising therapy for CRPC as well as preventing castration resistance. However, at present, the application to therapeutics is limited. Therefore, further research on oxidative stress in prostate cancer, as well as on the development for clinical application would be needed.

Original languageEnglish
Pages (from-to)2131-2135
Number of pages5
JournalNihon rinsho. Japanese journal of clinical medicine
Volume72
Issue number12
Publication statusPublished - Dec 1 2014

Fingerprint

Androgen Receptors
Castration
Prostatic Neoplasms
Oxidative Stress
Reactive Oxygen Species
Therapeutics
Post Translational Protein Processing
Antioxidants
Research

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

[The development of therapeutics targeting oxidative stress in prostate cancer]. / Shiota, Masaki; Yokomizo, Akira; Naito, Seiji.

In: Nihon rinsho. Japanese journal of clinical medicine, Vol. 72, No. 12, 01.12.2014, p. 2131-2135.

Research output: Contribution to journalArticle

@article{ae934ecbfcf54c67b715af8cfaeb9c06,
title = "[The development of therapeutics targeting oxidative stress in prostate cancer]",
abstract = "Oxidative stress is caused by increased reactive-oxygen species (ROS) due to augmented ROS production and impaired anti-oxidative capacity. Recently, oxidative stress has been revealed to promote castration resistance via androgen receptor(AR)-dependent pathway such as AR overexpression, AR cofactor, and AR post-translational modification as well as AR-independent pathway, leading to the emergence of castration-resistant prostate cancer (CRPC). Therefore, antioxidants therapy using natural and chemical ROS scavengers and inhibitors of ROS production seems to be a promising therapy for CRPC as well as preventing castration resistance. However, at present, the application to therapeutics is limited. Therefore, further research on oxidative stress in prostate cancer, as well as on the development for clinical application would be needed.",
author = "Masaki Shiota and Akira Yokomizo and Seiji Naito",
year = "2014",
month = "12",
day = "1",
language = "English",
volume = "72",
pages = "2131--2135",
journal = "Astrophysical Journal",
issn = "0004-637X",
publisher = "IOP Publishing Ltd.",
number = "12",

}

TY - JOUR

T1 - [The development of therapeutics targeting oxidative stress in prostate cancer]

AU - Shiota, Masaki

AU - Yokomizo, Akira

AU - Naito, Seiji

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Oxidative stress is caused by increased reactive-oxygen species (ROS) due to augmented ROS production and impaired anti-oxidative capacity. Recently, oxidative stress has been revealed to promote castration resistance via androgen receptor(AR)-dependent pathway such as AR overexpression, AR cofactor, and AR post-translational modification as well as AR-independent pathway, leading to the emergence of castration-resistant prostate cancer (CRPC). Therefore, antioxidants therapy using natural and chemical ROS scavengers and inhibitors of ROS production seems to be a promising therapy for CRPC as well as preventing castration resistance. However, at present, the application to therapeutics is limited. Therefore, further research on oxidative stress in prostate cancer, as well as on the development for clinical application would be needed.

AB - Oxidative stress is caused by increased reactive-oxygen species (ROS) due to augmented ROS production and impaired anti-oxidative capacity. Recently, oxidative stress has been revealed to promote castration resistance via androgen receptor(AR)-dependent pathway such as AR overexpression, AR cofactor, and AR post-translational modification as well as AR-independent pathway, leading to the emergence of castration-resistant prostate cancer (CRPC). Therefore, antioxidants therapy using natural and chemical ROS scavengers and inhibitors of ROS production seems to be a promising therapy for CRPC as well as preventing castration resistance. However, at present, the application to therapeutics is limited. Therefore, further research on oxidative stress in prostate cancer, as well as on the development for clinical application would be needed.

UR - http://www.scopus.com/inward/record.url?scp=84922230292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922230292&partnerID=8YFLogxK

M3 - Article

C2 - 25518346

AN - SCOPUS:84922230292

VL - 72

SP - 2131

EP - 2135

JO - Astrophysical Journal

JF - Astrophysical Journal

SN - 0004-637X

IS - 12

ER -